Journal of Tissue Viability
Volume 17, Issue 3 , Pages 95-97 , August 2008

Clindamycin-resistant Clostridium perfringens cellulitis

References 

  1. Rood JI, Cole ST. Molecular genetics and pathogenesis of Clostridium perfringens. Microbiol Rev. 1991;55(4):621–648
  2. Awad MM, Bryant AE, Stevens DL, Rood JI. Virulence studies on chromosomal alpha-toxin and theta toxin mutants constructed by allelic exchange provide genetic evidence for the essential role of alpha-toxin in Clostridium perfringens-mediated gas gangrene. Mol Microbiol. 1995;15:191
  3. Kasper DL, Zaleznik DF. Gas gangrene, antibiotic-associated colitis, and other Clostridial infections. In:  Fauci AS,  Braunwald E,  Isselbacher KJ,  Wilson JD,  Martin JB,  Kasper DL editor. Harrison's principles of internal medicine. 14th ed.. New York: McGraw-Hill; 1998;p. 906–910
  4. Gorbach SL. Clostridium perfringens and other clostridia. In:  Gorbach SL,  Bartlett JG,  Blacklow NR editor. Infectious diseases. Philadelphia: WB Saunders; 1992;p. 1587
  5. Lorber B. Gas gangrene and other Clostridium-associated diseases. In:  Mandell GL,  Bennett JE,  Dolin R editor. Principles and practice of infectious diseases. 6th ed.. Philadelphia, PA: Churchill Livingstone; 2005;p. 2828
  6. Stevens DL, Maier KA, Laine BM, Mitten JE. Comparison of clindamycin, rifampin, tetracycline, metronidazole, and penicillin for efficacy in prevention of experimental gas gangrene due to Clostridium perfringens. J Infect Dis. 1987;155:220
  7. Aldridge KED, Ashcraft D, Cambre K, Pierson CL, Jenkins SG, Rosenblatt JE. Multicenter survey of changing in vitro antimicrobial susceptibilities of clinical isolates of Bacteroides fragilis group, Prevotella, Fusobacterium, Porphyromonas and Peptostreptococcus species. Antimicrobial Agents Chemother. 2001;45:1238–1243
  8. Roberts SA, Shore KP, Paviour SD, Holland D, Morris AJ. Antimicrobial susceptibility of anaerobic bacteria in New Zealand: 1999–2003. J Antimicorb Chemother. 2006;57:992–998
  9. Claeys LGY, Matamoros R. Anaerobic cellulitis as the result of Clostridium perfringens: a rare cause of vascular access graft infection. J Vasc Surg. 2002;35:1287–1288
  10. Bryant P, Carapetis J, Matussek J, Curtis N. Recurrent crepitant cellulitis caused by Clostridium perfringens. Pediatr Infect Dis J. 2002;21:1173–1174

PII: S0965-206X(08)00018-1

doi: 10.1016/j.jtv.2008.04.001

Journal of Tissue Viability
Volume 17, Issue 3 , Pages 95-97 , August 2008